Industry
Medical - Devices
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
September 29, 2023 | 12:30 pm
Portfolio Pulse from Vandana Singh
September 15, 2023 | 5:46 pm
Portfolio Pulse from Benzinga Newsdesk
September 15, 2023 | 4:18 pm
Portfolio Pulse from Benzinga Insights
September 15, 2023 | 3:52 pm
Portfolio Pulse from Benzinga Newsdesk
September 15, 2023 | 11:45 am
Portfolio Pulse from Lisa Levin
September 07, 2023 | 5:19 pm
Portfolio Pulse from Benzinga Newsdesk
September 07, 2023 | 2:04 pm
Portfolio Pulse from Benzinga Insights
September 06, 2023 | 2:00 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.